Roseomonas mucosa significantly improved symptoms in children with AD, reduced S. aureus colonization and repaired the skin barrier through a lipid-mediated TNFR2-EMT repair pathway, and was safe (100). This evidence concerns the gene TNFRSF1B and Alzheimer disease.